Todd J. Lorenz

2.4k total citations · 1 hit paper
34 papers, 1.8k citations indexed

About

Todd J. Lorenz is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Todd J. Lorenz has authored 34 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 18 papers in Surgery and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Todd J. Lorenz's work include Coronary Interventions and Diagnostics (11 papers), Acute Myocardial Infarction Research (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (10 papers). Todd J. Lorenz is often cited by papers focused on Coronary Interventions and Diagnostics (11 papers), Acute Myocardial Infarction Research (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (10 papers). Todd J. Lorenz collaborates with scholars based in United States, Canada and United Kingdom. Todd J. Lorenz's co-authors include Michael M. Kitt, James E. Tcheng, Dennis F. Bandyk, Michael S. Conte, Gregory L. Moneta, Alexander W. Clowes, J.Conor O’Shea, Russell H. Samson, Hamid Namini and Michael Belkin and has published in prestigious journals such as JAMA, Circulation and Blood.

In The Last Decade

Todd J. Lorenz

31 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery

2006 479 citations Michael S. Conte, Dennis F. Bandyk et al. Journal of Vascular Surgery profile →

Peers

Todd J. Lorenz

CCM

SURGE

PRM

RNMI

Gisela Pogátsa-Murray Germany

Thomas Maca Austria

Prakash Saha United Kingdom

Karl-Ludwig Neuhaus Germany

Suzanne Fateh‐Moghadam Germany

Germano DiSciascio United States

James Cotton United Kingdom

Hamish Hart New Zealand

Patrizia Della Valle Italy

Michał Ząbczyk Poland

Gisela Pogátsa-Murray Germany

Todd J. Lorenz

1.4k ×1.5

CCM

967 ×1.0

SURGE

106 ×0.3

PRM

335 ×1.4

253 ×1.4

RNMI

Citations per year, relative to Todd J. Lorenz Todd J. Lorenz (= 1×) peers Gisela Pogátsa-Murray

Countries citing papers authored by Todd J. Lorenz

Since Specialization

Citations

This map shows the geographic impact of Todd J. Lorenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd J. Lorenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd J. Lorenz more than expected).

Fields of papers citing papers by Todd J. Lorenz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd J. Lorenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd J. Lorenz. The network helps show where Todd J. Lorenz may publish in the future.

Co-authorship network of co-authors of Todd J. Lorenz

This figure shows the co-authorship network connecting the top 25 collaborators of Todd J. Lorenz. A scholar is included among the top collaborators of Todd J. Lorenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd J. Lorenz. Todd J. Lorenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lorenz, Todd J., et al.. (2021). Preparing Undergraduates for Agriculture and Food Research Careers: An Internship Paradigm. Journal of Extension. 59(Spring 2021).

Cohen, Alexander T, Robert A. Harrington, Samuel Z. Goldhaber, et al.. (2013). The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study. American Heart Journal. 167(3). 335–341. 71 indexed citations

Hernandez, Adrian F., Christopher M. O’Connor, Randall C. Starling, et al.. (2008). Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). American Heart Journal. 157(2). 271–277. 119 indexed citations

Ye, Weiguo, Yun Zhou, Mohab Alexander, et al.. (2007). Receptor occupancy following chronic or single daily dosing with naltrexone. 48. 2 indexed citations

Conte, Michael S., Dennis F. Bandyk, Alexander W. Clowes, et al.. (2006). Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. Journal of Vascular Surgery. 43(4). 742–751.e1. 479 indexed citations breakdown →

Halabi, Abdul R., John H. Alexander, Linda K. Shaw, et al.. (2005). Relation of Early Saphenous Vein Graft Failure to Outcomes Following Coronary Artery Bypass Surgery. The American Journal of Cardiology. 96(9). 1254–1259. 82 indexed citations

Alexander, John H., T. Bruce Ferguson, Michael J. Mack, et al.. (2005). The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial. American Heart Journal. 150(4). 643–649. 43 indexed citations

Tcheng, James E., J.Conor O’Shea, Bonnie H. Weiner, et al.. (2002). Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?. Journal of the American College of Cardiology. 40(6). 1085–1091. 42 indexed citations

Gibson, C. Michael, Sabina A. Murphy, Susan J. Marble, et al.. (2002). Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: An ESPRIT substudy. American Heart Journal. 143(1). 106–110. 33 indexed citations

10.

Gibson, C. Michael, Eric A. Cohen, Henry Lui, et al.. (2001). Effect of eptifibatide on coronary flow reserve following coronary stent implantation (An ESPRIT substudy). The American Journal of Cardiology. 87(11). 1293–1295. 29 indexed citations

11.

O’Shea, J.Conor, Gail E. Hafley, Sally Greenberg, et al.. (2001). Platelet Glycoprotein IIb/IIIa Integrin Blockade With Eptifibatide in Coronary Stent Intervention. JAMA. 285(19). 2468–2468. 160 indexed citations

12.

Kereiakes, Dean J., et al.. (2001). Differential Effects of Citrate Versus PPACK Anticoagulation on Measured Platelet Inhibition by Abciximab, Eptifibatide and Tirofiban. Journal of Thrombosis and Thrombolysis. 12(2). 123–127. 25 indexed citations

13.

Dyke, Cornelius M., Devinder Bhatia, Todd J. Lorenz, et al.. (2000). Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: results from PURSUIT. The Annals of Thoracic Surgery. 70(3). 866–871. 63 indexed citations

14.

Lorenz, Todd J., Fraser MacDonald, & Michael M. Kitt. (1999). Nonimmunogenicity of eptifibatide, a cyclic heptapeptide inhibitor of platelet glycoprotein IIb–IIIa. Clinical Therapeutics. 21(1). 128–137. 6 indexed citations

15.

Ronner, Eelko, et al.. (1998). Combined therapy with streptokinase and integrilin. Journal of the American College of Cardiology. 31. 191–191. 25 indexed citations

16.

Horrigan, M., James E. Tcheng, Robert M. Califf, et al.. (1996). Maximal benefit of integrelin platelet IIB/IIIa blockade 6–24 hours after therapy: Results of the IMPACT-II trial. Journal of the American College of Cardiology. 27(2). 55–55. 5 indexed citations

17.

Zidar, James P., Dean J. Kereiakes, Joseph B. Muhlestein, et al.. (1996). Integrelin for emergency coronary artery stenting. Journal of the American College of Cardiology. 27(2). 138–138. 13 indexed citations

18.

Olsen, Nancy J., Raye H. Brooks, John J. Cush, et al.. (1996). A double‐blind, placebo‐controlled study of anti‐CD5 immunoconjugate in patients with rheumatoid arthritis. Arthritis & Rheumatism. 39(7). 1102–1108. 33 indexed citations

19.

Kimmings, A N, Nancy Wedel, Marcel L.C.M. Mevissen, et al.. (1995). Inhibition of Endotoxin-Induced Cytokine Release and Neutrophil Activation in Humans by Use of Recombinant Bactericidal/Permeability-Increasing Protein. The Journal of Infectious Diseases. 172(1). 144–151. 98 indexed citations

20.

Lorenz, Todd J.. (1990). Orthodontic considerations of the impacted canine.. PubMed. 1(1). 12–21. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact